16th IBD Intensive Advanced Course

Date
Feb 14-15, 2018
Time 
Feb 14, 2018: 08:45-16:45
Feb 15, 2018: 07:45-12:00
Organisation
EduCom
Target audience 
Junior gastroenterologists
Registration
Upon invitation only - Application deadline: September 8, 2017
ECCO Membership
Regular/Y-ECCO Membership 2018 - register/renew now!
Registration fee
n.a.
Please contact the ECCO Office in case of questions at This email address is being protected from spambots. You need JavaScript enabled to view it.


16th IBD Intensive Advanced Course
(as of December 2017)

  • 08:45-09:00 Arrival and distribution of voting pads
    09:00–09:10 1: Welcome 
    Julián Panés, Barcelona, Spain
    James Lindsay, London, United Kingdom
    09:10–10:10 Session 1: Pathogenesis
    Lead discussant: James Linsay, London, United Kingdom
    09:10-09:25 2: Exposome
    Jonas Halfvarson, Örebrö, Sweden
    09:25-09:40 3: Genetics
    Miles Parkes, Cambridge, United Kingdom
    09:40-09:55 4: Inflammatory pathways
    Yehuda Chowers, Haifa, Israel
      09:55-10:05 Discussion / Questions
    10:05-10:20 Coffee break
    10:20-11:35 Session 2: Drug management session. Part I: Conventional drugs
    Lead discussant: Antonio López-Sanromán, Madrid, Spain
    10:20-10:40 5: 5-ASA compounds
    Gerhard Rogler, Zurich, Switzerland
    10:40-11:00 6: Thiopurines
    Peter Irving, London, United Kingdom
      11:00-11:15 7: Methotrexate
    Pascale Juillerat, Bern, Switzerland
    11:15-11:35 8: Steroids
    Stephan Vavricka, Zurich, Switzerland
    11:35-12:55 Session 2: Drug management session. Part II: Biologics
    Lead discussant: Séverine Vermeire, Leuven, Belgium
    11:35-11:55 9: Anti-TNF agents
    Filip Baert, Roeselare, Belgium
    11:55-12:10 10: Vedolizumab
    James Lindsay, London, United Kingdom
    12:10-12:25 11: Ustekinumab
    Marc Ferrante, Leuven, Belgium
      12:25-12:40 12: Tofacitinib
    Séverine Vermeire, Leuven, Belgium
      12:40-12:55 Discussion / Question
    12:55–13:30 Lunch break
    13:30-15:00 Session 3: Seminars. Part I: Special clinical situations
    13:30-14:15 EITHER:
    13a: Managing IBD and pregnancy
    Janneke van der Woude, Rotterdam, The Netherlands
    Iris Dotan, Tel Aviv, Israel
    OR:
    13b: Managing extraintestinal manifestations of IBD

    Stephan Vavricka, Zurich, Switzerland
    Peter Lakatos, Budapest, Hungary; Montreal, Canada
    14:15-15:00 EITHER:
    13a: Managing IBD and
    pregnancy
    Janneke van der Woude, Rotterdam, The Netherlands
    Iris Dotan, Tel Aviv, Israel

    OR:
    13b: Managing extraintestinal manifestations of IBD
    Stephan Vavricka, Zurich, Switzerland
    Peter Lakatos, Budapest, Hungary; Montreal, Canada
    15:00–15:15  Coffee break
    15:15–16:45 Session 3: Seminars. Part II: Long term management
    15:15-16:00 EITHER:
    14a: Managing complications associated with anti-TNF therapy
    Shomron Ben-Horin, Ramat Gan, Israel
    Axel Dignass, Frankfurt am Main, Germany
    OR: 
    14b: Perform endoscopy and IBD incl. chromo-endoscopy, balloon dilation
    Pierre Michetti, Lausanne, Switzerland
    Marc Ferrante, Leuven, Belgium
     16:00-16:45  EITHER:
    14a: Managing complications associated with anti-TNF therapy
    Shomron Ben-Horin, Ramat Gan, Israel
    Axel Dignass, Frankfurt am Main, Germany
    OR: 
    14b: Perform endoscopy and IBD incl. chromo-endoscopy, balloon dillation

    Pierre Michetti, Lausanne, Switzerland
    Marc Ferrante, Leuven, Belgium
  • 07:45-09:25 Session 4: Interactive case discussions
    Lead discussant: Ailsa Hart, London, United Kingdom
    07:45-08:30 15: Case-based discussion: Fistulising Crohn's Disease:  Medical and surgical approaches
    Antonio López-Sanromán, Madrid, Spain
    Paulo Kotze, Curitiba, Brazil; Calgary, Canada

    08:30-08:35 Discussion 
    08:35–09:20 16: Case-based discussion: Optimal management of patient with severe Crohn's disease treated with anti-TNF agents
    Case presentation:
    Michael Fitzpatrick, Oxford, United Kingdom

    Discussion:
    Simon Travis, Oxford, United Kingdom
    09:20-09:25 Discussion
    09:25-09:45 Coffee break
    09:45-11:50 Session 5: Special cases scenarios
    Lead discussant: Gerassimos Mantzaris, Athens, Greece
    09:45–10:15 17: Medical management of acute severe ulcerative colitis
    Corey Siegel, Lebanon, United States
    10:15-10:45 18: Management of refractory pouchitis
    Iris Dotan, Tel Aviv, Israel

    10:45-11:15 19: Pre- and postoperative management of Crohn's Disease 
    Glen Doherty, Dublin, Israel
    11:15-11:50 20: Case based discussion: Investigation and management of mild/moderate Crohn's Disease
    Case presentation: Tim Raine, Cambridge, United Kingdom
    Discussion: Larry Egan, Galway, Ireland

    11:50-12:00 Feedback and closing remarks
    Pascale Juillerat, Bern, Switzerland